MirimGene is a bio-venture company that develops first-in-class innovative drugs
for the treatment of intractable infections and immune diseases.


We aim to become a global biopharmaceutical company that saves the lives of patients suffering from diseases and improves their quality of life. MirimGENE will do this by developing innovative therapeutics for infectious and intractable immune diseases with no cure and high mortality rates.

  • Mission


    We develop biopharmaceuticals for patients who cannot be treated with existing treatment to provide hope with newly developed drugs.


    We will implement precision medicine by developing therapeutics that simultaneously diagnose and treat diseases.

Core values